Form 8-K - Current report:
SEC Accession No. 0000950170-25-090374
Filing Date
2025-06-26
Accepted
2025-06-26 16:01:34
Documents
10
Period of Report
2025-06-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K scyx-20250620.htm   iXBRL 8-K 44460
  Complete submission text file 0000950170-25-090374.txt   149938

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20250620.xsd EX-101.SCH 24862
12 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20250620_htm.xml XML 4706
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 251080303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)